380 related articles for article (PubMed ID: 33433656)
1. Effects of a patient-tailored integrative oncology intervention in the relief of pain in palliative and supportive cancer care.
Ben-Arye E; Elly D; Samuels N; Gressel O; Shulman K; Schiff E; Lavie O; Minerbi A
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2361-2372. PubMed ID: 33433656
[TBL] [Abstract][Full Text] [Related]
2. Impact of a combined integrative oncology and palliative care program on quality of life of patients with advanced cancer.
Ben-Arye E; Yakubov Y; Samuels N; Gressel O; Yosipovich A; Schiff E; Ophir M; Saliba W; Dagash J
Med Oncol; 2021 Jul; 38(8):93. PubMed ID: 34241706
[TBL] [Abstract][Full Text] [Related]
3. Exploring the effectiveness of a patient-tailored integrative oncology program on emotional distress during chemotherapy for localized cancer.
Ben-Arye E; Elly M; Gressel O; Reshef A; Shani Md M; Stein N; Saliba W; Samuels N
Psychooncology; 2022 Feb; 31(2):207-218. PubMed ID: 34435403
[TBL] [Abstract][Full Text] [Related]
4. Inverse relationship between reduced fatigue and severity of anemia in oncology patients treated with integrative medicine: understanding the paradox.
Ben-Arye E; Dahan O; Shalom-Sharabi I; Samuels N
Support Care Cancer; 2018 Dec; 26(12):4039-4048. PubMed ID: 29882024
[TBL] [Abstract][Full Text] [Related]
5. Effect of a 12-week integrative oncology intervention on gastro-intestinal concerns in patients with gynecological and breast cancer undergoing chemotherapy.
Shalom-Sharabi I; Keinan-Boker L; Samuels N; Lavie O; Lev E; Ben-Arye E
Med Oncol; 2017 Sep; 34(9):155. PubMed ID: 28779424
[TBL] [Abstract][Full Text] [Related]
6. Correlation between an integrative oncology treatment program and survival in patients with advanced gynecological cancer.
Segev Y; Lavie O; Stein N; Saliba W; Samuels N; Shalabna E; Raz OG; Schiff E; Ben-Arye E
Support Care Cancer; 2021 Jul; 29(7):4055-4064. PubMed ID: 33404816
[TBL] [Abstract][Full Text] [Related]
7. Effect of a patient-tailored integrative medicine program on gastro-intestinal concerns and quality of life in patients with breast and gynecologic cancer.
Shalom-Sharabi I; Samuels N; Lavie O; Lev E; Keinan-Boker L; Schiff E; Ben-Arye E
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1243-1254. PubMed ID: 28247032
[TBL] [Abstract][Full Text] [Related]
8. Impact of a patient-tailored complementary/integrative medicine programme on disturbed sleep quality among patients undergoing chemotherapy.
Kerner H; Samuels N; Ben Moshe S; Sharabi IS; Ben-Arye E
BMJ Support Palliat Care; 2020 Sep; 10(3):e21. PubMed ID: 28710110
[TBL] [Abstract][Full Text] [Related]
9. Quality-of-life outcomes in patients with gynecologic cancer referred to integrative oncology treatment during chemotherapy.
Ben-Arye E; Samuels N; Schiff E; Raz OG; Sharabi IS; Lavie O
Support Care Cancer; 2015 Dec; 23(12):3411-9. PubMed ID: 25752885
[TBL] [Abstract][Full Text] [Related]
10. Alleviating gastro-intestinal symptoms and concerns by integrating patient-tailored complementary medicine in supportive cancer care.
Ben-Arye E; Aharonson ML; Schiff E; Samuels N
Clin Nutr; 2015 Dec; 34(6):1215-23. PubMed ID: 25556349
[TBL] [Abstract][Full Text] [Related]
11. Quality of life-related outcomes from a patient-tailored integrative medicine program: experience of Russian-speaking patients with cancer in Israel.
Sharabi IS; Levin A; Schiff E; Samuels N; Agour O; Tapiro Y; Lev E; Keinan-Boker L; Ben-Arye E
Support Care Cancer; 2016 Oct; 24(10):4345-55. PubMed ID: 27169571
[TBL] [Abstract][Full Text] [Related]
12. Association Between Physical Activity and Use of Complementary Medicine by Female Oncology Patients in an Integrative Palliative Care Setting.
Gressel Raz O; Samuels N; Levy M; Leviov M; Lavie O; Ben-Arye E
J Altern Complement Med; 2020 Aug; 26(8):721-728. PubMed ID: 32678704
[No Abstract] [Full Text] [Related]
13. Impact of a complementary/integrative medicine program on the need for supportive cancer care-related medications.
Shalom-Sharabi I; Samuels N; Lev E; Lavie O; Keinan-Boker L; Schiff E; Ben-Arye E
Support Care Cancer; 2017 Oct; 25(10):3181-3190. PubMed ID: 28434097
[TBL] [Abstract][Full Text] [Related]
14. A Quality Brief of an Oncological Multisite Massage and Acupuncture Therapy Program to Improve Cancer-Related Outcomes.
Fink J; Burns J; Perez Moreno AC; Kram JJF; Armstrong M; Chopp S; Maul SJ; Conway N
J Altern Complement Med; 2020 Sep; 26(9):820-824. PubMed ID: 32924553
[No Abstract] [Full Text] [Related]
15. Providing integrative care in the pre-chemotherapy setting: a pragmatic controlled patient-centered trial with implications for supportive cancer care.
Ben-Arye E; Dahly H; Keshet Y; Dagash J; Samuels N
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1825-1833. PubMed ID: 29980837
[TBL] [Abstract][Full Text] [Related]
16. Assessing patient adherence to a complementary medicine treatment regimen in an integrative supportive care setting.
Ben-Arye E; Kruger D; Samuels N; Keinan-Boker L; Shalom T; Schiff E
Support Care Cancer; 2014 Mar; 22(3):627-44. PubMed ID: 24122407
[TBL] [Abstract][Full Text] [Related]
17. Predicting the risk for aberrant opioid use behavior in patients receiving outpatient supportive care consultation at a comprehensive cancer center.
Yennurajalingam S; Edwards T; Arthur JA; Lu Z; Najera J; Nguyen K; Manju J; Kuriakose L; Wu J; Liu D; Williams JL; Reddy SK; Bruera E
Cancer; 2018 Oct; 124(19):3942-3949. PubMed ID: 30192372
[TBL] [Abstract][Full Text] [Related]
18. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
19. Exploring an Integrative Patient-Tailored Complementary Medicine Approach for Chemotherapy-Induced Taste Disorders.
Ben-Arye E; Doweck I; Schiff E; Samuels N
Explore (NY); 2018; 14(4):289-294. PubMed ID: 29785939
[TBL] [Abstract][Full Text] [Related]
20. The effects of an integrated supportive care intervention on quality of life outcomes in outpatients with breast and gynecologic cancer undergoing chemotherapy: Results from a randomized controlled trial.
Klafke N; Mahler C; von Hagens C; Uhlmann L; Bentner M; Schneeweiss A; Mueller A; Szecsenyi J; Joos S
Cancer Med; 2019 Jul; 8(8):3666-3676. PubMed ID: 31115192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
